Efficacy and safety of mavrilimumab in Japanese subjects with rheumatoid arthritis: Findings from a Phase IIa study

Japan College of Rheumatology 2009 guidelines for the use of tocilizumab, a humanized anti-interleukin-6 receptor monoclonal antibody, in rheumatoid arthritis

(2014) Ryuji Koike et al.   Modern Rheumatology

Estimates of the prevalence of and current treatment practices for rheumatoid arthritis in Japan using reimbursement data from health insurance societies and the IORRA cohort (I)

(2013) Hisashi Yamanaka et al.   Modern Rheumatology

GM-CSF as a therapeutic target in inflammatory diseases

(2013) Annemarie van Nieuwenhuijze et al.   MOLECULAR IMMUNOLOGY

Efficacy and safety of mavrilimumab in subjects with rheumatoid arthritis

(2012) Gerd R Burmester et al.   ANNALS OF THE RHEUMATIC DISEASES

Protein engineering and preclinical development of a GM-CSF receptor antibody for the treatment of rheumatoid arthritis

(2012) RR Minter et al.   BRITISH JOURNAL OF PHARMACOLOGY

Current treatments of rheumatoid arthritis: from the ‘NinJa’ registry

(2012) Yukihiko Saeki et al.   Expert Review of Clinical Immunology

Evolution of treatment for rheumatoid arthritis

(2012) K. S. Upchurch et al.   RHEUMATOLOGY

Mavrilimumab, a human monoclonal antibody targeting GM-CSF receptor- , in subjects with rheumatoid arthritis: a randomised, double-blind, placebo-controlled, phase I, first-in-human study

(2011) G. R. Burmester et al.   ANNALS OF THE RHEUMATIC DISEASES

Mechanistic Modeling of Antigen Sink Effect for Mavrilimumab Following Intravenous Administration in Patients With Rheumatoid Arthritis

(2011) Bing Wang et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Analysis of Complex Biomarkers for Human Immune-Mediated Disorders Based on Cytokine Responsiveness of Peripheral Blood Cells

(2010) J. M. Davis et al.   JOURNAL OF IMMUNOLOGY

Rheumatoid arthritis

(2010) David L Scott et al.   LANCET

The Japanese experience with biologic therapies for rheumatoid arthritis

(2010) Tsutomu Takeuchi et al.   Nature Reviews Rheumatology

Pulmonary alveolar proteinosis, a primary immunodeficiency of impaired GM-CSF stimulation of macrophages

(2009) Bruce C Trapnell et al.   CURRENT OPINION IN IMMUNOLOGY

G-CSF and GM-CSF as therapeutic targets in rheumatoid arthritis

(2009) Ann L. Cornish et al.   Nature Reviews Rheumatology

Validation of the 28-joint Disease Activity Score (DAS28) and European League Against Rheumatism response criteria based on C-reactive protein against disease progression in patients with rheumatoid arthritis, and comparison with the DAS28 based on erythrocyte sedimentation rate

(2008) G Wells et al.   ANNALS OF THE RHEUMATIC DISEASES